SU5416 in Treating Patients With Advanced Solid Tumors

NCT00005642 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: semaxanib

Sponsor

Case Comprehensive Cancer Center

Collaborators

[object Object]